Oragenics (OGEN) Return on Capital Employed Growth (5y) (2016 - 2023)
Oragenics (OGEN) Return on Capital Employed Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -39,435.00 |
| Sep 30, 2023 | -5,616.00 |
| Jun 30, 2023 | 7,054.00 |
| Mar 31, 2023 | 2,338.00 |
| Dec 31, 2022 | 2,654.00 |
| Sep 30, 2022 | 17,150.00 |
| Jun 30, 2022 | 26,845.00 |
| Mar 31, 2022 | 32,887.00 |
| Dec 31, 2021 | 18,756.00 |
| Sep 30, 2021 | 10,716.00 |
| Jun 30, 2021 | 13,663.00 |
| Mar 31, 2021 | 23,165.00 |
| Dec 31, 2020 | 1,602.00 |
| Sep 30, 2020 | 23,800.00 |
| Jun 30, 2020 | 5,961.00 |
| Mar 31, 2020 | -5,780.00 |
| Dec 31, 2019 | -2,672.00 |
| Sep 30, 2019 | -187.00 |
| Jun 30, 2019 | 6,748.00 |
| Mar 31, 2019 | 6,114.00 |